| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Bridgewater Associates · Ray Dalio | $4.9M | 0.02% | 58.99K | +84% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Rob Bresnahan PA08 | 1 | +$8.0K | Bought Apr 8, 25 | |
| Julie Johnson TX32 | 1 | −$8.0K | Sold Apr 1, 25 | |
| Gilbert Cisneros CA31 | 1 | −$8.0K | Sold Mar 31, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Apr 8, 25 | Rob Bresnahan PA08 | Self | Buy | $1,001 - $15,000 | May 8, 25 (30d) | |
| Apr 1, 25 | Julie Johnson TX32 | Joint | Sell | $1,001 - $15,000 | May 14, 25 (43d) | |
| Mar 31, 25 | Gilbert Cisneros CA31 | Self | Sell | $1,001 - $15,000 | Apr 7, 25 (7d) |
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Daniel William KDirector | Stock Award(Grant) at price 0.00 per share. | 2.2K | — |
| May 25, 2026 | Bergman Stanley MDirector | Stock Gift at price 0.00 per share. | 50 | — |
| May 20, 2026 | Bergman Stanley MDirector | Stock Gift at price 0.00 per share. | 50 | — |
| May 18, 2026 | Bergman Stanley MDirector | Stock Gift at price 0.00 per share. | 1K | — |
| May 10, 2026 | Daniel William KDirector | Purchase at price 69.19 per share. | 10K | $691.90K |
| Mar 18, 2026 | Popeck Thomas COfficer | Sale at price 72.79 per share. | 1.4K | $98.63K |
| Mar 16, 2026 | Ettinger Michael S.Chief Operating Officer | Stock Gift at price 0.00 per share. | 2.3K | — |
| Mar 15, 2026 | Bergman Stanley MDirector | Stock Gift at price 0.00 per share. | 400 | — |
| Mar 11, 2026 | Bergman Stanley MDirector | Stock Gift at price 0.00 per share. | 970 | — |
| Mar 9, 2026 | Kuehn Kurt PDirector | Sale at price 78.96 per share. | 2.8K | $224.56K |
| Mar 5, 2026 | Laskawy Philip ADirector | Stock Award(Grant) at price 0.00 per share. | 2.6K | — |
| Mar 5, 2026 | Sheares Bradley TDirector | Stock Award(Grant) at price 0.00 per share. | 2.6K | — |
| Mar 5, 2026 | Derby Deborah M.Director | Stock Award(Grant) at price 0.00 per share. | 2.6K | — |
| Mar 5, 2026 | Kuehn Kurt PDirector | Stock Award(Grant) at price 0.00 per share. | 2.6K | — |
| Mar 5, 2026 | Hombach Robert J. CpaDirector | Stock Award(Grant) at price 0.00 per share. | 2.6K | — |
| Mar 5, 2026 | Mlotek Mark EOfficer | Stock Gift at price 0.00 per share. | 1.5K | — |
| Mar 5, 2026 | Mlotek Mark EOfficer | Stock Award(Grant) at price 0.00 per share. | 27.1K | — |
| Mar 5, 2026 | Tuckson Reed VaughnDirector | Stock Award(Grant) at price 0.00 per share. | 2.6K | — |
| Mar 5, 2026 | Ettinger Michael S.Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | 27.1K | — |
| Mar 5, 2026 | Herring Joseph LDirector | Stock Award(Grant) at price 0.00 per share. | 2.6K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.1 | 9.2 | -10.5 | 1.2 | 2.7 | 9.1 | 2.7 | 4.7 | -6.5 | 0.3 | +11.4% | ||
| 2025 | 15.6 | -9.8 | -5.1 | -5.1 | 7.7 | 4.4 | -7.4 | 2.9 | -4.6 | -4.8 | 18.0 | 1.4 | +9.2% |
| 2024 | -1.1 | 2.2 | -1.2 | -8.3 | 0.1 | -7.6 | 12.2 | -1.9 | 3.3 | -3.7 | 9.7 | -10.2 | −8.6% |
| 2023 | 7.9 | -9.1 | 4.1 | -0.9 | -8.6 | 9.7 | -2.8 | -2.9 | -3.0 | -12.5 | 2.7 | 13.5 | −5.2% |
| 2022 | -2.9 | 14.7 | 0.9 | -7.0 | 5.6 | -10.4 | 2.7 | -6.9 | -10.4 | 4.1 | 18.2 | -1.3 | +3.0% |
| 2021 | -1.5 | -6.1 | 11.9 | 4.7 | 4.9 | -2.4 | 8.0 | -5.7 | 0.8 | 0.2 | -6.9 | 9.1 | +16.0% |
| 2020 | 3.3 | -11.6 | -17.1 | 8.0 | 11.3 | -3.8 | 17.7 | -3.3 | -11.5 | 8.2 | 1.1 | 4.0 | +0.2% |
| 2019 | -1.0 | -2.7 | 1.4 | 6.6 | 0.6 | 8.4 | -4.8 | -7.4 | 3.1 | -1.4 | 10.1 | -3.2 | +8.3% |
| 2018 | 8.3 | -12.5 | 1.5 | 13.1 | -8.9 | 5.0 | 9.3 | -2.2 | 9.5 | -2.4 | 7.5 | -12.0 | +12.4% |
| 2017 | 5.4 | 7.3 | -0.9 | 2.3 | 5.9 | -0.5 | -0.4 | -4.7 | -5.6 | -4.1 | -9.1 | -2.2 | −7.9% |
| 2016 | -4.3 | 9.3 | 4.3 | -2.3 | 3.0 | 1.8 | 2.4 | -9.5 | -0.5 | -8.5 | -0.2 | 1.8 | −4.1% |
| 2015 | 1.4 | 1.4 | -0.3 | -1.8 | 3.3 | 0.3 | 4.1 | -7.5 | -3.0 | 14.3 | 3.1 | 1.1 | +16.2% |
| 2014 | 0.6 | 3.6 | 0.3 | -4.3 | 4.7 | -0.8 | -2.0 | 3.0 | -2.7 | 3.1 | 14.3 | -0.8 | +19.2% |
| 2013 | 7.4 | 3.3 | 3.7 | -2.3 | 6.5 | -0.6 | 8.4 | -2.7 | 2.7 | 8.3 | 1.4 | 0.2 | +42.1% |
| 2012 | 10.0 | 4.4 | 2.2 | 1.4 | -3.2 | 5.6 | -4.7 | 2.7 | 3.1 | -6.9 | 9.5 | -0.4 | +24.8% |
| 2011 | 7.0 | 5.1 | 1.7 | 4.1 | -1.7 | -0.3 | -7.2 | -0.8 | -5.9 | 11.8 | -7.2 | 0.1 | +5.0% |
| 2010 | 2.8 | 5.1 | 3.6 | 2.7 | -6.8 | -2.7 | -4.4 | 0.6 | 10.9 | -4.1 | 2.2 | 7.0 | +16.7% |
| 2009 | 2.0 | -2.0 | 9.0 | 2.6 | 11.0 | 5.3 | 7.2 | 3.1 | 3.6 | -3.8 | -6.0 | 5.9 | +43.4% |
| 2008 | -5.3 | 2.9 | -4.0 | -3.5 | 0.6 | -7.4 | 3.9 | 9.2 | -7.9 | -13.1 | -23.7 | 2.7 | −40.2% |
| 2007 | 3.7 | 2.8 | 5.8 | -5.5 | 2.7 | -0.2 | 1.7 | 7.1 | 4.6 | -1.5 | -1.3 | 3.8 | +25.4% |
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Buy / hold / sell counts